BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30867003)

  • 21. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
    Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
    Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
    Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
    Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
    J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
    Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
    Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
    Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
    Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
    Salim H; Arvanitis A; de Petris L; Kanter L; Hååg P; Zovko A; Özata DM; Lui WO; Lundholm L; Zhivotovsky B; Lewensohn R; Viktorsson K
    Genes Chromosomes Cancer; 2013 Oct; 52(10):895-911. PubMed ID: 23929716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits.
    Stellas D; El Hamidieh A; Patsavoudi E
    BMC Cell Biol; 2010 Jul; 11():51. PubMed ID: 20602761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
    Yang N; Liang Y; Yang P; Ji F
    Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
    Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
    Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
    Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.
    Zhang X; Yu X; Jiang G; Miao Y; Wang L; Zhang Y; Liu Y; Fan C; Lin X; Dong Q; Han Q; Zhao H; Han Y; Han X; Rong X; Ding S; Wang E; Wang E
    Cancer Res; 2015 Nov; 75(21):4527-37. PubMed ID: 26359454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
    Li H; Lin PH; Gupta P; Li X; Zhao SL; Zhou X; Li Z; Wei S; Xu L; Han R; Lu J; Tan T; Yang DH; Chen ZS; Pawlik TM; Merritt RE; Ma J
    Mol Cancer; 2021 Sep; 20(1):118. PubMed ID: 34521423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
    Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
    Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.